EUVIMEDOpdag EUVIMED
Übersichtsarbeit

USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion

Zike Li, Dongjing Zhang, Siqi Chen, Xin Zhang, Zhihong Wang, Changsheng Huang, Qi Wu, Anyi Liu, Kangdi Li, Ziran Wei, Junbo Hu iD

Reviews in Medical Virology · 2026-05 · 36 (3)

DOI: 10.1002/rmv.70145 ↗

At a glance

Übersichtsarbeit in Reviews in Medical Virology, published online on 2026-04-16. Written by Zike Li and 10 co-authors. Institution: GI Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China. Major MEDLINE topics: Ubiquitin Thiolesterase, Immune Evasion, Oncogenic Viruses, Host-Pathogen Interactions. 57 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ubiquitination is a critical post‐translational modification that regulates protein stability, signalling pathways, and cellular homoeostasis. Increasing evidence shows that oncogenic viruses exploit the host ubiquitin system to promote viral persistence, immune evasion, and malignant transformation. Among the various host factors targeted, deubiquitinating enzymes (DUBs) play a pivotal role because they reverse ubiquitination, thereby regulating the stability, localization, and activity of key signalling proteins. Ubiquitin‐specific peptidase 10 (USP10) has emerged as a particularly critical DUB in the context of viral tumourigenesis, functioning as a molecular rheostat that balances tumour suppression and oncogenic progression. The dysregulation of USP10 by viral oncoproteins facilitates a dual assault on the host: the subversion of innate immune sensors, specifically the RIG‐I, MAVS, and cGAS‐STING pathways, and the evasion of adaptive immune surveillance through the stabilisation of immune checkpoints, such as PD‐L1, and the disruption of MHC‐I antigen presentation. This comprehensive analysis explores the biochemical architecture of USP10, its paradoxical roles in cancer, and the specific mechanisms through which oncogenic viruses exploit this enzyme to drive malignancy and immune escape.

Subjects

MeSH terms (MEDLINE)

Ubiquitin ThiolesteraseImmune EvasionOncogenic VirusesHost-Pathogen InteractionsNeoplasmsCarcinogenesisHumansAnimalsSignal TransductionUbiquitination

Author keywords

USP10oncovirusestumourigenesisubiquitination

Substances

Ubiquitin ThiolesteraseUSP10 protein, human

Authors and institutions

  • GI Cancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gastrointestinal Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.

ORCID profiles: Junbo Hu

Cite

APA

Li, Z., Zhang, D., Chen, S., Zhang, X., Wang, Z., Huang, C., Wu, Q., Liu, A., Li, K., Wei, Z., & Hu, J. (2026). USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion. Reviews in Medical Virology, 36(3). https://doi.org/10.1002/rmv.70145

Vancouver

Li Z, Zhang D, Chen S, Zhang X, Wang Z, Huang C, et al. USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion. Reviews in Medical Virology. 2026;36(3). doi:10.1002/rmv.70145

BibTeX
@article{Li2026,
  author = {Li, Zike and Zhang, Dongjing and Chen, Siqi and Zhang, Xin and Wang, Zhihong and Huang, Changsheng and Wu, Qi and Liu, Anyi and Li, Kangdi and Wei, Ziran and Hu, Junbo},
  title = {USP10 Dysregulation in Oncogenic Virus‐Driven Tumourigenesis and Immune Evasion},
  journal = {Reviews in Medical Virology},
  year = {2026},
  volume = {36},
  number = {3},
  doi = {10.1002/rmv.70145}
}
Start for free →